Integrin targeting liposome for nucleic acid delivery

Details Integrin targeting liposome for nucleic acid delivery Integrin targeting liposome for nucleic acid delivery

A - Human Necessities

61

K

A61K 48/00 (2006.01) A61K 9/127 (2006.01) A61K 47/48 (2006.01) A61K 51/12 (2006.01) C12N 15/63 (2006.01) C12N 15/88 (2006.01)

Patent

CA 2449054

.alpha.v.beta.3 Integrin receptor targeting liposomes comprise a cationic amphiphile such as a cationic lipid, a neutral lipid, and a targeting lipid. The targeting lipid includes a non-peptidic .alpha.v.beta.3 integrin antagonist.

La présente invention concerne des liposomes ciblant le récepteur intégrine .alpha.¿v?.beta.¿3?, qui comprennent un amphiphile cationique tel qu'un lipide cationique, un lipide neutre et un lipide de ciblage. Le lipide de ciblage comprend un antagoniste non peptidique de l'intégrine .alpha.¿v?.beta.¿3?.

Affiliated with

Also associated with

Rating

Integrin targeting liposome for nucleic acid delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Integrin targeting liposome for nucleic acid delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin targeting liposome for nucleic acid delivery will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1435338